跳至主要内容
临床试验/NCT06212700
NCT06212700Unknown不适用

Virtual Multimodal Hub for Patients Undergoing Major Gastrointestinal Cancer Surgery - PRIORITY-CONNECT 2 Pilot Randomised Type I Hybrid Effectiveness-Implementation Trial

Surgical Outcomes Research Centre (SOuRCe)4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年2月12日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
4
主要终点
Feasibility of the virtual multimodal hub determined by number of eligible participants, retention rate and adherence rates

研究概览

简要总结

The provision of preoperative interventions (prehabilitation: including exercise, nutrition, and psychological treatment) have been reported to reduce postoperative complications by as much as 50% and reduce hospital stay by up to 4 days compared to standard of care. Postoperative multimodal interventions are likely to further benefit patients facing new challenges (e.g. stoma care), and reduce post discharge complications.

Therefore the Virtual Multimodal hub of PRIORITY-CONNECT 2 Pilot Trial aims to primarily; determine the feasibility of incorporating a virtual multimodal program into the preoperative and postoperative period for patients undergoing gastrointestinal cancer surgery, the acceptability to patients, clinicians and carers of the virtual multimodal program and the acceptability to patients of being randomised to the virtual multimodal program or usual care.

The secondary aim is to obtain pilot data on the likely difference in key outcomes (30 days postoperative complications, quality of life, days at home and alive at 30 days - DAH30, implementation outcomes and cost outcomes) to inform the development of a substantive randomised clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Consenting participants will undergo baseline assessment immediately prior to randomisation to intervention (virtual multimodal hub and usual care) or control group (usual care alone). The randomisation sequence will be prepared a priori using a central secure randomisation service (1:1 allocation ratio in random permuted blocks of sizes 4 or 2 stratified by hospital, to ensure balance intreatment assignment within hospital) to ensure concealment of treatment allocation and blinding of surgeon, all trial personnel and statistician. Due to the nature of the intervention, it is not possible to blind the clinicians delivering the intervention (virtual multimodal hub); however, the investigators will ensure that all patients' interactions are standardised.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged ≥18 years undergoing major gastrointestinal elective surgery, including liver, pancreas, oesophagus, gastric and colorectal cancer resections with curative intent
  • Consulting with a gastrointestinal cancer surgeon at least 1 week prior to scheduled surgery

排除标准

  • Cognitive impairment such that they are unable to provide informed consent
  • No access to a smart device (including mobile phone, tablet, laptop or desk computer with camera) or no internet connection

结局指标

主要结局

Feasibility of the virtual multimodal hub determined by number of eligible participants, retention rate and adherence rates

时间窗: through study completion, an average of 1 year

Feasibility will be determined by the following outcomes: (i) Number of eligible participants recruited to the pilot trial; (ii) Retention rate: defined as the percentage of participants who completed the trial; (iii) Adherence rates: defined as the percentage of planned sessions attended by those who were randomised to the intervention group.

Acceptability of the virtual multimodal hub.

时间窗: 3 months, through study completion, an average of 1 year

Patients, clinicians and carers acceptability to the virtual multimodal hub (Intervention) will be assessed with a semi-structured questionnaire administered at 3-months (last survey). The semi- structured questionnaire contains 11 questions and participants (Patients, clinicians and carers) will be instructed to use a 5-point Likert Scale to express how much they agree or disagree with each statement. In addition, patients will be asked how satisfied they were with the virtual multimodal program and if the program negatively affected them. The investigators have also taken the opportunity to seek further feedback about the virtual multimodal hub (open ended question). The questionnaire has been used on previous pilot trials.

次要结局

  • Quality of life outcome EORTC QLQ-OG25(Measured at baseline, 1-2 day(s) before surgery, day of hospital discharge, 1- and 3-months post index surgery.)
  • Implementation Outcome: Reach(through study completion, an average of 1 year)
  • Implementation Outcome: Adoption(through study completion, an average of 1 year)
  • Postoperative complications within 30 days after surgery(30 days after surgery)
  • Quality of life outcome EORTC QLQ-C30(Measured at baseline, 1-2 day(s) before surgery, day of hospital discharge, 1- and 3-months post index surgery.)
  • Implementation Outcome: Effectiveness(through study completion, an average of 1 year)
  • Implementation Outcome: Implementation(through study completion, an average of 1 year)
  • Quality of life outcome EORTC QLQ-CR29(Measured at baseline, 1-2 day(s) before surgery, day of hospital discharge, 1- and 3-months post index surgery.)
  • Number of days at home within 30 and 90 days of surgery(days at home within 30 and 90 days of surgery)
  • Resource use(1-6 weeks prior to surgery to 3 months post index surgery.)
  • Implementation Outcome: Maintenance(through study completion, an average of 1 year)

研究者

发起方
Surgical Outcomes Research Centre (SOuRCe)
申办方类型
Network
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验